These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15272228)

  • 1. Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar typhi isolates showing reduced susceptibility to ciprofloxacin.
    Mandal S; Mandal MD; Pal NK
    Chemotherapy; 2004 Jun; 50(3):152-4. PubMed ID: 15272228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar typhi with reduced susceptibility to ciprofloxacin.
    Mandal S; Mandal MD; Pal NK
    Jpn J Infect Dis; 2003 Aug; 56(4):156-7. PubMed ID: 14583638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of ciprofloxacin alone and in combination with amoxycillin against Salmonella typhi isolates.
    Mandal S; Mandal M; Pal NK
    Indian J Exp Biol; 2003 Apr; 41(4):360-2. PubMed ID: 15255648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
    Threlfall EJ; Ward LR
    Emerg Infect Dis; 2001; 7(3):448-50. PubMed ID: 11384525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
    Mandal S; Mandal MD; Pal NK
    Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
    Gupta V; Kaur J; Kaistha N
    Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
    Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
    Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
    Pal NK; Mandal S; Mandal MD
    Int J Antimicrob Agents; 2004 Sep; 24(3):297-9. PubMed ID: 15325437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
    Ray P; Sharma J; Marak RS; Garg RK
    Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
    Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
    Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
    Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in antibiotic susceptibility of enteric fever isolates in East London.
    Dave J; Sefton A; de Pinna E; Woodford N; Meade R; Jordan M; Grant K; Holliman R; Millar M
    Travel Med Infect Dis; 2015; 13(3):230-4. PubMed ID: 25964222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
    Ahmed D; D'Costa LT; Alam K; Nair GB; Hossain MA
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3516-7. PubMed ID: 17005846
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
    Joshi S; Amarnath SK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.